观察CS术后1个月复发缺血事件与氯吡格雷抵抗的关系。
To investigate the relationship between the recurrence of ischemic events and clopidogrel resistance in 1 month after CS.
氯吡格雷抵抗包括对氯吡格雷无反应和对氯吡格雷低反应。
Clopidogrel resistance showed no response or low response to clopidogrel.
结论：PCI介入治疗的患者中存在部分氯吡格雷抵抗者。
Conclusions: Clopidogrel resistance occurs in some of the patients undergoing PCI.
目的：观察在经皮冠状动脉介入治疗（PCI）患者中硫酸氯吡格雷抵抗的发生情况。
Objective: To determine the relationship between risk factors of CHD and clopidogrel resistance, and CD62p expression after PCI.
但近年来的研究发现，有些患者存在氯吡格雷抵抗现象，即应用氯吡格雷治疗的患者仍会发生心血管血栓事件。
But recent studies have found that some patients exist clopidogrel resistant, that means some patients with clopidogrel treatment will still occur cardiovascular events.
氯吡格雷抵抗是临床上广泛使用的一个词汇，用来描述服用氯吡格雷而不能提供充分抗血小板作用的一种现象。
Clopidogrel resistance is a currently used term to describe the phenomenon in patients administrated with clopidogrel, but fail to provide adequate antiplatelet protection.
结果CYP3A4基因多态性在氯吡格雷抵抗（CR）组和非氯吡格雷抵抗（NCR）组的差异无统计学意义（P＞0.05）。
Results No significant difference was found in CYP3A4 gene polymorphism between patients with clopidogrel resistance (CR group) and those without CR (NCR group) (P>0.05).
目的观察氯吡格雷对缺血性脑血管病患者阿司匹林抵抗（AR）的影响。
Objective To explore the effect of clopidogrel bisulfate on aspirin resistance (AR) in patients with ischemic cerebrovascular disease.
目的观察氯吡格雷对缺血性脑血管病患者阿司匹林抵抗（AR）的影响。
Objective To explore the effect of clopidogrel bisulfate on aspirin resistance (AR) in patients with ischemic cerebrovascular disease.
应用推荐